Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023

SELL
$62.32 - $89.47 $1.29 Million - $1.85 Million
-20,717 Reduced 50.18%
20,570 $1.77 Million
Q3 2022

Oct 25, 2022

BUY
$59.54 - $68.01 $1.71 Million - $1.95 Million
28,681 Added 227.52%
41,287 $2.55 Million
Q2 2022

Aug 04, 2022

SELL
$57.72 - $65.01 $1.64 Million - $1.85 Million
-28,433 Reduced 69.28%
12,606 $779,000
Q1 2022

Apr 14, 2022

BUY
$57.92 - $72.58 $2.11 Million - $2.64 Million
36,353 Added 775.78%
41,039 $2.44 Million
Q4 2021

Jan 18, 2022

BUY
$64.88 - $73.64 $149,159 - $169,298
2,299 Added 96.31%
4,686 $340,000
Q1 2021

Apr 26, 2021

SELL
$60.0 - $68.46 $1.91 Million - $2.18 Million
-31,799 Reduced 93.02%
2,387 $154,000
Q4 2020

Jan 21, 2021

BUY
$56.65 - $64.55 $5,665 - $6,455
100 Added 0.29%
34,186 $1.99 Million
Q3 2020

Oct 27, 2020

SELL
$62.1 - $78.08 $452,336 - $568,734
-7,284 Reduced 17.61%
34,086 $2.15 Million
Q2 2020

Jul 22, 2020

BUY
$72.34 - $84.0 $443,588 - $515,088
6,132 Added 17.4%
41,370 $3.18 Million
Q1 2020

May 07, 2020

BUY
$62.63 - $80.22 $1.68 Million - $2.15 Million
26,802 Added 317.71%
35,238 $2.63 Million
Q4 2019

Feb 06, 2020

BUY
$61.62 - $67.78 $215,670 - $237,230
3,500 Added 70.91%
8,436 $548,000
Q3 2019

Oct 28, 2019

SELL
$62.51 - $69.0 $316,488 - $349,347
-5,063 Reduced 50.64%
4,936 $312,000
Q2 2019

Aug 09, 2019

SELL
$61.87 - $69.38 $419,478 - $470,396
-6,780 Reduced 40.41%
9,999 $675,000
Q1 2019

May 10, 2019

SELL
$62.53 - $70.05 $634,616 - $710,937
-10,149 Reduced 37.69%
16,779 $1.09 Million
Q4 2018

Feb 05, 2019

SELL
$60.54 - $79.0 $700,084 - $913,556
-11,564 Reduced 30.04%
26,928 $1.68 Million
Q3 2018

Nov 07, 2018

BUY
$71.28 - $78.92 $16,822 - $18,625
236 Added 0.62%
38,492 $2.97 Million
Q2 2018

Aug 10, 2018

BUY
$64.88 - $75.68 $594,560 - $693,531
9,164 Added 31.5%
38,256 $2.71 Million
Q1 2018

May 11, 2018

SELL
$72.84 - $88.8 $892,581 - $1.09 Million
-12,254 Reduced 29.64%
29,092 $2.19 Million
Q4 2017

Jan 17, 2018

BUY
$71.15 - $83.52 $620,926 - $728,879
8,727 Added 26.75%
41,346 $2.96 Million
Q3 2017

Oct 17, 2017

BUY
$72.11 - $85.47 $2.35 Million - $2.79 Million
32,619
32,619 $2.64 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.